Last reviewed · How we verify

Topical Antibiotic

Hamilton Health Sciences Corporation · FDA-approved active Small molecule ✓ Verified May 2026 Quality 2/100

Topical Antibiotic is a Small molecule drug developed by Hamilton Health Sciences Corporation. It is currently FDA-approved.

Topical antibiotic is used to treat various conditions, including Central Centrifugal Cicatricial Alopecia, Spinal Fusion Acquired, Diabetic Macular Edema, Age Related Macular Degeneration, and Branch Retinal Vein Occlusion With Macular Edema, according to ClinicalTrials.gov. However, the exact mechanism of action of topical antibiotic is unknown, as stated by ChEMBL.

At a glance

Generic nameTopical Antibiotic
SponsorHamilton Health Sciences Corporation
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Topical Antibiotic

What is Topical Antibiotic?

Topical Antibiotic is a Small molecule drug developed by Hamilton Health Sciences Corporation.

Who makes Topical Antibiotic?

Topical Antibiotic is developed and marketed by Hamilton Health Sciences Corporation (see full Hamilton Health Sciences Corporation pipeline at /company/hamilton-health-sciences-corporation).

What development phase is Topical Antibiotic in?

Topical Antibiotic is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing